ELV Elevance Health
- Official Name: ELEVANCE HEALTH, INC.
- Headquarters: 220 Virginia Avenue, INDIANAPOLIS, IN, 46204 US
- CEO: Gail Koziara Boudreaux
- Website: elevancehealth.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-14 | 1 | Lost by 3.556 | (1.511) - 2.045 | ||
| 2025-07-21 | 2 | Lost by 8.557 | (8.312) - 0.245 | ||
| 2025-07-28 | 3 | Won by 5.195 | 7.659 - 2.464 | ||
| 2025-07-29 | 2R | Won by 1.146 | 0.912 - (0.234) | ||
| 2025-08-04 | 4 | Lost by 5.111 | (1.077) - 4.034 | ||
| 2025-08-06 | 1R | Lost by 1.343 | 0.091 - 1.434 | ||
| 2025-08-07 | 1R | Won by 3.637 | 2.224 - (1.413) | ||
| 2025-08-11 | 5 | Won by 4.253 TOTW | 4.616 - 0.363 | ||
| 2025-08-12 | 3R | Lost by 1.628 | 0.623 - 2.251 | ||
| 2025-08-18 | 6 | Won by 1.194 TOTW | 5.382 - 4.188 | ||
| 2025-08-21 | 2R | Won by 0.250 | (0.277) - (0.527) | ||
| 2025-08-25 | 7 | Won by 5.003 | 4.085 - (0.918) | ||
| 2025-09-01 | 8 | Won by 2.194 | 1.599 - (0.595) | ||
| 2025-09-04 | 3R | Lost by 2.169 | (4.357) - (2.188) | ||
| 2025-09-08 | 9 | Lost by 0.431 | (3.490) - (3.059) | ||
| 2025-09-15 | 10 | Won by 5.685 | (0.496) - (6.181) | ||
| 2025-09-22 | 11 | Won by 5.988 | 3.573 - (2.415) | ||
| 2025-09-29 | 12 | Won by 5.188 | 0.594 - (4.594) | ||
| 2025-10-06 | 13 | Won by 8.610 | 9.223 - 0.613 | ||
| 2025-10-13 | 14 | Won by 3.931 | 0.435 - (3.496) | ||
| 2025-10-20 | 15 | Won by 0.282 | 0.797 - 0.515 |
Latest News

Where Could UnitedHealth's Next Growth Come From?
UnitedHealth Group (UNH) could find its next growth engine in the care it delivers. That perspective carries weight right now. During the company'...

Which S&P500 stocks are moving before the opening bell on Friday?
Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.

Unveiling Elevance Health (ELV) Q3 Outlook: Wall Street Estimates for Key Metrics
Besides Wall Street's top-and-bottom-line estimates for Elevance Health (ELV), review projections for some of its key metrics to gain a deeper un...

Elevance Q3 Earnings Preview: Will Lower Premiums Weigh on Results?
Can ELV overcome a 4.9% premium decline and weaker Health Benefits income? Membership losses add pressure, though higher product revenues may offer so...

What Happened With UnitedHealth Stock This Week?
Shares of UnitedHealth Group (UNH) rose 4.5% over the two trading days through Wednesday, October 14, while the S&P 500 fell 1.1%. The company rep...

UnitedHealth is Down Big Over 3 Months: A Big Bank Says 40% Gains to Come After Raising Their Target
UnitedHealth has shed members, slipped 10% in three months, and closed lower on a beat-and-raise quarter. Now a major Wall Street firm is calling for ...

Centene's Gold Card Push Could Ease Costs - But Will Savings Follow?
Centene's nationwide Gold Card program aims to streamline prior authorization and cut administrative costs, but adoption and actual savings will ...

Oscar Health Raises 2026 Operating Earnings Outlook as Margins Improve
Oscar Health raises its 2026 operating earnings outlook to $500M-$700M as pricing gains and tech efficiencies lift margins, despite rising churn and m...

Is Oscar Health Stock a Buy as Growth Surges but Valuation Stays Rich?
Oscar Health's surging revenue, membership gains and improving profitability bolster its growth story, but premium valuation and churn risks clou...

Oscar Health Rallies 14.9% in 3 Months: Can the Gains Keep Going?
Oscar Health shares have surged 14.9% in three months, fueled by membership growth, better underwriting and cost efficiencies. Can the rally continue?

UnitedHealth Rises 4% on Earnings Beat and Raised Full-Year Outlook; Humana Advances 2%
UnitedHealth crushed earnings estimates and lifted its full-year outlook, but the number driving its medical cost improvement raises a critical questi...

Humana leads Managed Care winners in new CMS Star Ratings - Evercore
Investing.com -- Managed care insurers face divergent earnings impacts from the Centers for Medicare and Medicaid Services' 2027 Star Ratings, wi...
Guggenheim Maintains Buy on Elevance Health, Raises Price Target to $460
Guggenheim analyst Jason Cassorla maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $455 to $460.